Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "C"

10617 News Found

Illumina showcases multi-omics potential to advance precision medicine in India
Biopharma | May 08, 2026

Illumina showcases multi-omics potential to advance precision medicine in India

The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru


Yashoda Medicity unveils specialised thalassemia care centre in Uttar Pradesh
Hospitals | May 08, 2026

Yashoda Medicity unveils specialised thalassemia care centre in Uttar Pradesh

The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services


Microsure secures CE mark for MUSA-3 system, appoints Alex Joseph as CEO
Medical Device | May 08, 2026

Microsure secures CE mark for MUSA-3 system, appoints Alex Joseph as CEO

The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform


Dr. Mansukh Mandaviya to launch nationwide Free Annual Health Check-Up today
Policy | May 07, 2026

Dr. Mansukh Mandaviya to launch nationwide Free Annual Health Check-Up today

These check-ups will be conducted through ESIC’s extensive network of hospitals, with a focus on early diagnosis, preventive healthcare, and continuous health monitoring


CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection
News | May 07, 2026

CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection

Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China


Safic-Alcan expands in India with majority stake in SA Ingredients
News | May 07, 2026

Safic-Alcan expands in India with majority stake in SA Ingredients

The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint


Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics
News | May 07, 2026

Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics

The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy


Venus Remedies gets marketing authorization for Ceftriaxone in Argentina
Drug Approval | May 07, 2026

Venus Remedies gets marketing authorization for Ceftriaxone in Argentina

Approval strengthens the company’s growing international anti-infective portfolio


Danone India and UP govt. introduce Iron-Anthem to drive anemia awareness
Policy | May 07, 2026

Danone India and UP govt. introduce Iron-Anthem to drive anemia awareness

The 40-second film brings children to the forefront of the narrative


GIMS Greater Noida expands paediatric orthopaedic care under Healthium's CSR initiative
Hospitals | May 07, 2026

GIMS Greater Noida expands paediatric orthopaedic care under Healthium's CSR initiative

Supported by Plan International, the partnership will help treat over 1,000 children annually